This stock defied the market correction. Here’s why it could keep rising
Subscribe to enjoy similar stories. Over the last six months, the stock of Narayana Hrudayalaya has risen by over 30% against an 8.3% decline in the Sensex, outperforming the benchmark index by a wide margin. The stock has also been an outlier amid the recent correction, bucking the trend.
It recently hit its 52-week high of ₹1,725. Shares of the company have been on the radar of investors for multiple reasons: Expanding capacities, diversification into other fields, and strengthening operational efficiency. Let’s examine each of them and assess whether the company has the financials to support them.
Narayana Hrudayalaya has planned a capex of ₹1,400-1,600 crore for 2024-25. Around ₹280 crore will be used towards the multi-specialty hospital in the Cayman Islands. The capex for 2025-26 to 2028-29 includes replacement and maintenance capex of around ₹300-350 crore per year along with ₹900-1,200 crore per year for brownfield and greenfield expansion.
The company is actively exploring brownfield acquisitions, expanding capacity in key cities like Bengaluru and Kolkata, which is expected to boost growth. It recently announced investment plans for a hospital in Kolkata. The company plans to invest ₹900 crore for the first phase, aiming for a 1,100-bed facility over the next three to 10 years.
Once fully operational, the hospital plans to increase Narayana Health's total bed capacity in Kolkata to 2,500, reinforcing the region's position as a hub for advanced healthcare. The company is also planning to add 2,000 new beds in the upcoming four to five years, which will require an investment of ₹4,000-5,000 crore. The company is currently focused on setting up two greenfield facilities, one in Kolkata (350 new beds in the first
. Read on livemint.com